---
title: 'Therapeutic Reference Range for Olanzapine in Schizophrenia: Systematic Review
  on Blood Concentrations, Clinical Effects, and Dopamine Receptor Occupancy'
date: '2023-07-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37471567/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230720211418&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'Objective: Aiming at revising the therapeutic reference range for olanzapine,
  the present study highlights the association between blood olanzapine levels, clinical
  effects, and dopamine D(2)-receptor occupancy for oral and long-acting injectable
  (LAI) ...'
disable_comments: true
---
Objective: Aiming at revising the therapeutic reference range for olanzapine, the present study highlights the association between blood olanzapine levels, clinical effects, and dopamine D(2)-receptor occupancy for oral and long-acting injectable (LAI) ...